APM
XNAS
$0.70
Aptorum Group Limited Class A Ordinary Shares (APM)
Aptorum Group Limited, a pharmaceutical company, is dedicated to the discovery, development and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. The company is headquartered in London, the United Kingdom.
Sector:
Healthcare
Industry:
Biotechnology
Target: $80 (+11328.57%)
Market Cap
$6.01M
P/B Ratio
0.29
Free Cash Flow Yield
-30.54%
Beta (5Y)
0.77
Price Chart
Valuation
Market Cap$6.01M
P/S23.35
P/B0.29
Profitability
Gross Profit (TTM)$5.25K
EBITDA-$1.36M
EPS-$0.19
Financial Health
Free Cash Flow Yield-30.54%
Growth & Risk
EPS 5Y CAGR-52.59%
Beta (5Y)0.77
Sharpe Ratio0.26